Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
ABSTRACT H7N9 avian influenza virus (AIV) is an emerging zoonotic pathogen, and it is necessary to develop a differentiating infected from vaccinated animals (DIVA) vaccine for the purpose of eradication. H7N9 subtype AIV hemagglutinin subunit 2 glycoprotein (HA2) peptide chips and antisera of diffe...
Main Authors: | Zhihao Sun, Qiuxia Wang, Gang Li, Jingzhi Li, Sujuan Chen, Tao Qin, Hongwei Ma, Daxin Peng, Xiufan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-10-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/Spectrum.00687-21 |
Similar Items
-
Generation of an avian influenza DIVA vaccine with a H3-peptide replacement located at HA2 against both highly and low pathogenic H7N9 virus
by: Gang Li, et al.
Published: (2022-12-01) -
Identification of a universal antigen epitope of influenza A virus using peptide microarray
by: Qiuxia Wang, et al.
Published: (2021-01-01) -
Serological Evaluation of Turkey Herpesvirus Vector Vaccines Expressing the Hemagglutinin Gene of Avian Influenza Virus H5 Subtype under Three Different Promoters
by: Motoyuki Esaki, et al.
Published: (2015-01-01) -
Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study
by: A.G. Pose, et al.
Published: (2015-09-01) -
Evaluation of a commercial ELISA kit (IDEXX) to differentiate AI virus-infected poultry from AI-vaccinated poultry (DIVA)
by: F Talazadeh, et al.
Published: (2014-06-01)